Navigation Links
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Date:7/8/2008

First Organ-specific MRI Contrast Agent Approved in the United States in

More Than a Decade

WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has approved EOVIST(R) (Gadoxetate Disodium) Injection, a gadolinium-based contrast agent, for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease. The approval makes EOVIST the first organ-specific MRI contrast agent approved in the United States in more than a decade.

"The approval of EOVIST in the United States marks a significant achievement in advancing the accurate diagnosis of liver disease," said Douglas Stefanelli, Vice President and General Manager, Diagnostic Imaging, Bayer HealthCare Pharmaceuticals. "This milestone demonstrates Bayer HealthCare Pharmaceuticals' commitment to providing innovative imaging products that can help improve the lives of patients."

EOVIST is a paramagnetic MRI contrast agent that combines features of both an extracellular contrast agent and a hepatocyte-specific agent. EOVIST is administered via an intravenous, bolus injection and has a dual route of excretion with approximately 50 percent eliminated through the liver and 50 percent eliminated through the kidney. Detection and characterization of malignant and benign focal liver lesions with EOVIST may help enhance diagnostic accuracy and increase diagnostic confidence.

"EOVIST-enhanced images can provide more comprehensive information about focal liver lesions in a single, short imaging session than was previously available," said Jeffrey Brown, MD, Professor of Radiology, Washington University School of Medicine, St. Louis. "With the availability of EOVIST, our ability to evaluate patients with benign and malignant focal hepatic lesions will
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
2. FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents
3. FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
4. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
5. Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
6. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
7. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
8. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
9. FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
10. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
11. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009).... today announced a collaborative research agreeme...t evaluating EpiVax’s proprietary Tregitope ...ntal immune responses to certain drugs. In the cou...Tregitope technology will be evaluated for its eff...s. , (Vocus) December 2, ...
(Date:12/1/2009)...ANCOUVER, British Columbia, Dec. 1 /PRNewswire-Fir...bsidiary of The Dow Chemical Company (NYSE: DOW ...the signing of a research and commercial license o...iences with access to Agrisoma,s proprietary Engin...basis in major food crops, and on a non-exclusive ...
(Date:12/1/2009)..., a leading provider of products for biological sa...aceutical Services will offer Oragene•DNA sam...traction and genotyping service. , ...DNA Genotek , a leading provider of products for b... Tepnel Pharmaceutical Services will offer Orage...
(Date:12/1/2009)...Drapp, a 34-year veteran of the high-technology in... business development and intellectual property ma...ology space. The company also plans to invest in ... incubator. , Monterey, C...a 34-year veteran of the high-technology industry,...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
...Than 60,000 Women Underscores Need for Better Unde...ated with Osteoporosis, MONTREAL, Sept. 15 Resul...sis in Women (GLOW) showed that 55 percent of wome...are at a higher risk of,fractures than their peers...0,000 women over age 55 and was presented today at...
...paign Breaks Down Policy and Funding Barriers and ...ient Approach, KAKAMEGA, Kenya, Sept. 15 A new a...nd HIV was launched today in the Western,Kenyan di...campaign will provide a basic care package consist...ted bed net, a LifeStraw(R) water,purification too...
...h., Sept. 12 Stryker,Corporation (NYSE: SYK ) an...rsday, October 16, 2008 at 4:30 p.m., Eastern Time...he quarter ended September 30, 2008 and,provide an...rter ended,September 30, 2008 will be released at ...ence call dial 800-299-9630 (domestic) or,617-786-...
Other Biology Technology:Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 2Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 3Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease 2Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease 3Stryker to Host Conference Call on October 16, 2008 2
(Date:12/1/2009)... . , Brown adipose tissue is different from wh...miniature power stations which among other things ...ate a voltage similar to that of a battery, which ...er, the mitochondria of brown fat cells have a sho... The energy released when the fat is broken down i...
(Date:12/1/2009)...s by sharks can be solved with a new technique tha... put on their victims, according to a University o...thod analogous to analyzing human fingerprints, sc...paring shark bites to the jaws and teeth of the po... the International Shark Attack File, which is hou...
(Date:12/1/2009)...to the radio anymore. They,re used in everything f...h Carolina State University is revolutionizing the...antennas that open the door to a host of new uses ...eployment. , Modern antennas are made from coppe...w far they can be bent and how often before they...
Breaking Biology News(10 mins):Brown fat cells make 'spare tires' shrink 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Shape shifters: Researchers create new breed of antennas 2NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2WebMD Launches New Consumer Health Portal in the U K 5630 1WebMD Launches New Consumer Health Portal in the U K 5630 2WebMD Launches New Consumer Health Portal in the U K 5630 3Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 59887 1Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 59887 2Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 59887 3
...s a condition that greatly increases the risk of ...ty of a key protein that protects the heart and bl...sity School of Medicine have found. , Their find...nt heart disease the leading cause of death in th...bout other diseases associated with high cholester...
...nd conducted by scientists Carlos Duarte, Nuria Ag...te for Advanced Studies (CSIC University of the B...ation of a universal rule that explains the equili...ure the survival of their species whether their li... The research project, whose results will appear i...
...s ago as a way to improve fishing bait in Californ... a significant finding about how animal species in...onservation. , In the middle of the 20th century,... bait introduced a new species of salamander to Ca...ers came into contact with the native California T...
Other Biology News:Research explains link between cholesterol and heart disease 2A study proposes a new universal rule to explain the equilibrium of plant populations 2UT researcher sheds new light on hybrid animals 2UT researcher sheds new light on hybrid animals 3
...for investigating dynamic events in cells and subc...ve been limited at wavelengths longer than 370 nm ...eep UV. HORIBA Jobin Yvon, the leader in fluoresce...al system (the DynaMic) to measure fluorescence li...
Corning Gaps Ii Bar-Coded Coated Slides from Sigma-Aldrich
...es using many of the automation concepts from High...equirements are similar to those for HTS: Low vol... 48 wells with well volumes of 100s of microliters...ncreased to 96 or 384. High Speed: Dispensing ope...
...eroxidase activity utilizing a non-fluorescent sub... H2O2 oxidizes ADHP in a 1:1 stoichiometry to prod... 530-571 nm, emission at 590-600 nm). This reactio...neous, no wash assay system. ADHP can be utilized ...
Biology Products: